Set up in 2018, Invivocue is a bioscience company that aims to support medical and pharmaceutical research through its humanized rodent models. Invivocue was formed as a joint venture between Invitrocue, an innovative life sciences company providing in vitro liver models for drug toxicology testing as well as 3D patient-derived organoid technology for personalized oncology, and Dr Chen Qing Feng, a Principal Investigator at the Institute of Molecular and Cell Biology, whose research expertise focuses on humanized mouse models for various disease applications.